CN106074784A - The Chinese medicine for the treatment of coronary heart disease and myocardial ischemia - Google Patents
The Chinese medicine for the treatment of coronary heart disease and myocardial ischemia Download PDFInfo
- Publication number
- CN106074784A CN106074784A CN201610658039.1A CN201610658039A CN106074784A CN 106074784 A CN106074784 A CN 106074784A CN 201610658039 A CN201610658039 A CN 201610658039A CN 106074784 A CN106074784 A CN 106074784A
- Authority
- CN
- China
- Prior art keywords
- parts
- heart disease
- coronary heart
- myocardial ischemia
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/648—Myriapods, e.g. centipedes or millipedes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Insects & Arthropods (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A kind of Chinese medicine treating coronary heart disease, myocardial ischemia；It is characterized in that making by following raw material medical material formula: the Radix Astragali 15～25 parts, Radix Paeoniae Rubra 5～10 parts, Radix Salviae Miltiorrhizae 5～10 parts, Radix Angelicae Sinensis 5～10 parts, Radix Notoginseng 5～10 parts, Rhizoma Chuanxiong 10～20 parts, Flos Carthami 5～10 parts, cattle sunset 5～10 parts, Semen Persicae 5～10 parts, Olibanum 5～10 parts, Myrrha 5～10 parts, Scolopendra 1～2 parts.The present invention treats the Chinese medicine of coronary heart disease, myocardial ischemia, and it has the beneficial effects that: use the righting of the traditional Chinese medical science, eliminating evil two big rules, and during invigorating middle warmer residence is logical, logical, residence is mended, fortune mends double executing, to reach to treat myocardial ischemia, effect of coronary heart disease；It is applicable to the patient of myocardial ischemia, angina pectoris, coronary heart disease, sutable for men, women, and children；Its scientific formula is reasonable, and compatibility is original, evident in efficacy, have treating both the principal and secondary aspects of a disease, have no side effect, the feature of instant effect.Production method of the present invention is simple, low cost, applicable private clinic evolution are cured the disease, and is also suitable for situation of all-level hospitals preparation and pharmaceutical factory produces Chinese patent medicine.
Description
Technical field
The present invention relates to a kind of Chinese medicine, particularly relate to a kind of Chinese medicine treating coronary heart disease, myocardial ischemia.
Background technology
The function of heart is mainly the organ for whole body, tissue provides sufficient blood and nutrition, to maintain body just
Often need and metabolism；The various factors in health self or the external world all can affect the function of its heart, as heart cannot be fine
Transmit sufficient blood and nutrition, human body will show a series of pathological state, say, that human body now is intentionally
Disease of ZANG-organs；Heart disease mainly shows as coronary heart disease, myocardial ischemia, and this is also the modal cardiovascular disease of middle-aged and elderly people.At present,
Treatment coronary heart disease, myocardial ischemia medicine more, Chinese medicine and western medicine has；And Chinese medicine has better tolerance, the features such as side effect is little, controlling
Treat coronary heart disease, myocardial ischemia aspect has obvious advantage；And research and develop effect and preferably treat coronary heart disease, myocardial ischemia
Chinese medicine, always Chinese physician and the scientific research task of pharmacist.
Summary of the invention
In view of the above problems, the present invention provides a kind of Chinese medicine treating coronary heart disease, myocardial ischemia；Use the traditional Chinese medical science righting,
Eliminating evil two big rules, during invigorating middle warmer residence is logical, logical, residence is mended, fortune mends double executing, to reach to treat myocardial ischemia, effect of coronary heart disease；Its group
Side is scientific and reasonable, and compatibility is original, evident in efficacy；Have treating both the principal and secondary aspects of a disease, have no side effect, the feature of instant effect.
The present invention treats the Chinese medicine of coronary heart disease, myocardial ischemia, it is characterised in that by following raw material medical material formula system
Become:
The Radix Astragali 15～25 parts, Radix Paeoniae Rubra 5～10 parts, Radix Salviae Miltiorrhizae 5～10 parts, Radix Angelicae Sinensis 5～10 parts, Radix Notoginseng 5～10 parts, Rhizoma Chuanxiong 10～
20 parts, Flos Carthami 5～10 parts, cattle sunset 5～10 parts, Semen Persicae 5～10 parts, Olibanum 5～10 parts, Myrrha 5～10 parts, Scolopendra 1～2 parts.
The present invention treats the Chinese medicine of coronary heart disease, myocardial ischemia, and preferred weight part of raw medicinal material formula is:
The Radix Astragali 20 parts, Radix Paeoniae Rubra 8 parts, Radix Salviae Miltiorrhizae 8 parts, Radix Angelicae Sinensis 8 parts, Radix Notoginseng 8 parts, Rhizoma Chuanxiong 15 parts, 8 parts of Flos Carthami, cattle sunset 8 parts, Fructus Persicae
Core 8 parts, Olibanum 8 parts, Myrrha 8 parts, Scolopendra 2 parts.
The present invention treats the Chinese medicine of coronary heart disease, myocardial ischemia, and its dosage form is pill.
The present invention treats the Chinese medicine of coronary heart disease, myocardial ischemia, and its dosage form can be any mouth described in pharmaceutics
Oral dosage form.
In the present invention, effect of each raw medicinal material is as follows:
The Radix Astragali: sweet in the mouth, slightly warm in nature, benefiting QI for strengthening the superficies, diuresis poison holding, evacuation of pus, expelling pus and promoting granulation；, lack of appetite weak for the deficiency of vital energy is just
Half congealed, sinking of QI of middle-JIAO, chronic diarrhea proctoptosis, blood deficiency and yellow complexion, can improve cardiac function.
Radix Paeoniae Rubra: bitter in the mouth, cool in nature, have blood stasis dispelling, relieve the pain, removing heat from blood, effect of detumescence.
Radix Salviae Miltiorrhizae: bitter in the mouth, cold nature, has blood circulation promoting and blood stasis dispelling, detumescence hemostasis, effect of anti-inflammatory analgetic；For treating angina pectoris, changing
Mercy myocardial ischemia, coronary artery dilator.
Radix Angelicae Sinensis: sweet in the mouth, arduous, warm in nature, enriches blood, invigorates blood circulation, and menstruction regulating and pain relieving has anti-hypoxia, arteriosclerosis, suppression platelet
Gathering, anti thrombotic action.
Radix Notoginseng: feeble QI, bitter in the mouth Hui Tian, dissipating blood stasis hemostasis, subduing swelling and relieving pain, soaping agents therein and flavones ingredient can invigorating blood circulation
The stasis of blood, blood fat reducing, be used for treating cardiovascular disease.
Rhizoma Chuanxiong: acrid in the mouth, warm in nature, blood circulation promoting and blood stasis dispelling, activating QI to alleviate the depression, wind-expelling pain-stopping, it is used for treating coronary heart diseases and angina pectoris.
Flos Carthami: acrid in the mouth, warm in nature, promoting blood circulation to restore menstrual flow, blood stasis dispelling, promoting the circulation of QI pain relieving, nourishes blood, and cures mainly blood stasis in the heart, is used for treating heart strand
Bitterly, coronary heart disease.
The acid of Niu Xi: bitter in the mouth, property are put down, and thin profit is descending, energy complementary energy is rushed down, and has effect of blood circulation promoting and blood stasis dispelling, invigorating the liver and kidney, bone and muscle strengthening.
Semen Persicae: bitter in the mouth, property are sweet flat, have blood circulation promoting and blood stasis dispelling, functions of loosening bowel relieving constipation.
Olibanum: nature and flavor toil, GUIXIN, liver, spleen channel, there is effect of blood-activating and qi-promoting, pain relieving, detumescence and promoting granulation；To qi depression to blood stasis
Caused angina pectoris, coronary heart disease have good curative effect.
Myrrha: acrid in the mouth, property are flat, have effect of dissipating blood stasis analgesic therapy, detumescence and promoting granulation；For treating heart and gallbladder void, stagnation of heart-blood etc.
Disease.
Scolopendra: pungent, warm, poisonous, relieving spasm by subduing liver-wind, dredge the meridian passage, detoxicating and resolving stagnation of pathogens；For treating rheumatism, stagnation of blood stasis
The angina pectoris that causes, coronary insufficiency.
The present invention treats the Chinese medicine of coronary heart disease, myocardial ischemia, its advantage and having the beneficial effects that: use the traditional Chinese medical science righting,
Eliminating evil two big rules, during invigorating middle warmer residence is logical, logical, residence is mended, fortune mends double executing, to reach to treat myocardial ischemia, effect of coronary heart disease；It is suitable for
In myocardial ischemia, angina pectoris, the patient of coronary heart disease, sutable for men, women, and children；Its scientific formula is reasonable, and compatibility is original, evident in efficacy,
Have treating both the principal and secondary aspects of a disease, have no side effect, the feature of instant effect.Production method of the present invention is simple, low cost, applicable private clinic evolution
Cure the disease, be also suitable for situation of all-level hospitals preparation and pharmaceutical factory produces Chinese patent medicine.
The clinical therapeutic efficacy of the present invention further explained below:
The present invention, through the clinical observation of more than two decades, selects myocardial ischemia, patient 100 example of coronary heart disease；Take medicine 60 days and unite
Meter, clinical cure 43 example, account for 43%；Effective 54 examples, account for 54%.；Total effective rate is 97%, and is difficult to recurrence.
Its model case is as follows:
1, patient female 73 years old；Have History of Coronary Heart Disease, left pain uncomfortable in chest, often show effect, other places hospital every year be in hospital once or two
Secondary；After taking the present invention 10 days, chest pain, phenomenon uncomfortable in chest alleviate, after taking the present invention one month, and transference cure；Follow up a case by regular visits to half a year,
Overworked idol has asthma, the most then can normal exercise, but occur again without the symptom before taking the present invention.
2, patient man 60 years old；Coronary heart disease, left pain uncomfortable in chest at nightfall pain very, hinders sleep, fear of cold xerostomia, dizzy weak, breathe hard,
It is in and alleviates from taking nitroglycerin every day；After taking the present invention 8 days, shortness of breath and fatigue symptom alleviates, after taking one month, and symptom
Disappear, after taking three months, transference cure and can light physical labor, follow up a case by regular visits to half a year and do not fall ill.
3, patient female 65 years old；Suffer from coronary heart disease 10 years, the most uncomfortable in chest, occasionally have chest pain, cardiopalmus of breathing hard, time regular incidence, time serious
Drop is treated；After taking the present invention 15 days, uncomfortable in chest, chest pain symptom and attack times reduce；After taking 60 days, can normal light body
Power is worked, and without coronary heart disease symptom, and sleep is the best, follows up a case by regular visits to half a year, non-re-pull.
4, patient female 56 years old；Deficiency myocardial blood supply at ordinary times, suffers from coronary heart disease 5 years；After taking the present invention one month, heart disease
Symptom alleviates, and giddy alleviates, no longer breathes hard；After taking 60 days, patient can light physical labor, deficiency myocardial blood supply transference cure,
Following up a case by regular visits to half a year, coronary heart disease occurs the most again.
5, patient female 66 years old；Coronary heart disease 9 years, tachypnea after activity, uncomfortable in chest, dreaming often and waking easily, dizziness, long-term oral administration dripping pill, or
Hospitalization；After taking the present invention 10 days, remission, after taking three months, transference cure, follow up a case by regular visits to after half a year, send out the most again
Sick.
Detailed description of the invention
In order to make those skilled in the art be better understood from the present invention, below in conjunction with embodiment, the present invention is made further
Explanation.
Embodiment 1
Take following weight raw medicinal material:
The Radix Astragali 150 grams, Radix Paeoniae Rubra 100 grams, Radix Salviae Miltiorrhizae 100 grams, Radix Angelicae Sinensis 100 grams, Radix Notoginseng 50 grams, Rhizoma Chuanxiong 100 grams, 50 grams of Flos Carthami,
Cattle sunset 50 grams, 50 grams of Semen Persicae, Olibanum 100 grams, Myrrha 100 grams, Scolopendra 10 grams.
Above-mentioned component is prepared by the oral Chinese medicine pill technique in " pharmaceutics ", and the present invention making 2 grams/10 treats hat
Cardiopathia, the medicine pill of myocardial ischemia.
Usage and dosage: the pill of the present invention be administered orally one time 10,3 times on the one, one after each meal；Points for attention: avoid raw meat peppery.
The present invention treats the Chinese medicine of coronary heart disease, myocardial ischemia, and above-mentioned component, by known method in " pharmaceutics ", can produce
Peroral dosage form described in any " pharmaceutics ".
Embodiment 2
Take following weight raw medicinal material:
The Radix Astragali 250 grams, Radix Paeoniae Rubra 50 grams, Radix Salviae Miltiorrhizae 50 grams, Radix Angelicae Sinensis 50 grams, Radix Notoginseng 100 grams, Rhizoma Chuanxiong 200 grams, 100 grams of Flos Carthami, cattle
Sunset 100 grams, 100 grams of Semen Persicae, Olibanum 50 grams, Myrrha 50 grams, Scolopendra 20 grams.
The present invention treats the Chinese medicine of coronary heart disease, myocardial ischemia, and the preparation technology of the medicine pill of above-mentioned component, usage are used
Amount, points for attention are same as in Example 1.
The present invention treats the Chinese medicine of coronary heart disease, myocardial ischemia, and above-mentioned component, by known method in " pharmaceutics ", can produce
Peroral dosage form described in any " pharmaceutics ".
Embodiment 3
Take following weight raw medicinal material:
The Radix Astragali 200 grams, Radix Paeoniae Rubra 80 grams, Radix Salviae Miltiorrhizae 80 grams, Radix Angelicae Sinensis 80 grams, Radix Notoginseng 80 grams, Rhizoma Chuanxiong 150 grams, 80 grams of Flos Carthami, Niu Xi
80 grams, 80 grams of Semen Persicae, Olibanum 80 grams, Myrrha 80 grams, Scolopendra 20 grams.
The present invention treats the Chinese medicine of coronary heart disease, myocardial ischemia, the preparation technology of oral Chinese medicine pill of above-mentioned component, usage
Consumption, points for attention are same as in Example 1.
The present invention treats the Chinese medicine of coronary heart disease, myocardial ischemia, and above-mentioned component, by known method in " pharmaceutics ", can produce
Peroral dosage form described in any " pharmaceutics ".
Claims (4)
1. the Chinese medicine treating coronary heart disease, myocardial ischemia, it is characterised in that make by following raw material medical material formula:
The Radix Astragali 15～25 parts, Radix Paeoniae Rubra 5～10 parts, Radix Salviae Miltiorrhizae 5～10 parts, Radix Angelicae Sinensis 5～10 parts, Radix Notoginseng 5～10 parts, Rhizoma Chuanxiong 10～20
Part, Flos Carthami 5～10 parts, cattle sunset 5～10 parts, Semen Persicae 5～10 parts, Olibanum 5～10 parts, Myrrha 5～10 parts, Scolopendra 1～2 parts.
Treatment coronary heart disease the most according to claim 1, the Chinese medicine of myocardial ischemia, it is characterised in that the weight of raw medicinal material formula
Amount part is:
The Radix Astragali 20 parts, Radix Paeoniae Rubra 8 parts, Radix Salviae Miltiorrhizae 8 parts, Radix Angelicae Sinensis 8 parts, Radix Notoginseng 8 parts, Rhizoma Chuanxiong 15 parts, 8 parts of Flos Carthami, cattle sunset 8 parts, Semen Persicae 8
Part, Olibanum 8 parts, Myrrha 8 parts, Scolopendra 2 parts.
Treatment coronary heart disease the most according to claim 1 and 2, the Chinese medicine of myocardial ischemia, it is characterised in that: described dosage form is ball
Agent.
Treatment coronary heart disease the most according to claim 1 and 2, the Chinese medicine of myocardial ischemia, it is characterised in that: described dosage form is medicine
Any peroral dosage form described in agent.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610658039.1A CN106074784A (en) | 2016-07-30 | 2016-07-30 | The Chinese medicine for the treatment of coronary heart disease and myocardial ischemia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610658039.1A CN106074784A (en) | 2016-07-30 | 2016-07-30 | The Chinese medicine for the treatment of coronary heart disease and myocardial ischemia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106074784A true CN106074784A (en) | 2016-11-09 |
Family
ID=57455690
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610658039.1A Pending CN106074784A (en) | 2016-07-30 | 2016-07-30 | The Chinese medicine for the treatment of coronary heart disease and myocardial ischemia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106074784A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113117017A (en) * | 2019-12-30 | 2021-07-16 | 睿特环中医药科技发展有限公司 | A Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases, and its preparation method |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104138566A (en) * | 2013-05-10 | 2014-11-12 | 哈尔滨济博生物技术开发有限公司 | Medicine for treating angina pectoris heart blood stasis type coronary heart disease |
-
2016
- 2016-07-30 CN CN201610658039.1A patent/CN106074784A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104138566A (en) * | 2013-05-10 | 2014-11-12 | 哈尔滨济博生物技术开发有限公司 | Medicine for treating angina pectoris heart blood stasis type coronary heart disease |
Non-Patent Citations (1)
| Title |
|---|
| 王翠微: "通补汤治疗气虚血瘀型冠心病心绞痛80例", 《辽宁中医杂志》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113117017A (en) * | 2019-12-30 | 2021-07-16 | 睿特环中医药科技发展有限公司 | A Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases, and its preparation method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101254272B (en) | Medicament for promoting coronary circulation and embolism resistance | |
| CN102698092A (en) | Traditional Chinese medicine composition for treating liver-Yang hyperactivity-type hypertension | |
| CN102274385B (en) | Medicament for treating nasosinusitis and preparation method thereof | |
| CN102114231B (en) | Medicine for treating arrhythmia | |
| CN102512552B (en) | Traditional Chinese medicine composition for treating exogenous fever | |
| CN106214986A (en) | A kind of Chinese medicine decoction treating cardiovascular and cerebrovascular disease | |
| CN103041145B (en) | Traditional Chinese medicine composition for treating exogenous fever | |
| CN106074784A (en) | The Chinese medicine for the treatment of coronary heart disease and myocardial ischemia | |
| CN103212041B (en) | Chinese medicinal composition treating coronary heart disease | |
| CN102430030B (en) | Chinese medicinal composition for treating bone impediment | |
| CN105796891A (en) | Traditional Chinese medicinal composition for treating epigastric pain | |
| CN106039152A (en) | Traditional Chinese medicine preparation for treating acute waist sprain | |
| CN101804108A (en) | Traditional Chinese medicine composition for treating neurogenic headache | |
| CN104117018A (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
| CN103212039A (en) | Traditional Chinese medicine composition for treating infantile cough caused by qi deficiency | |
| CN103028088B (en) | Traditional Chinese medicine composition for treating coronary heart disease and angina | |
| CN103263645B (en) | Gastritis and gastric ulcer treatment drug | |
| CN102641420B (en) | Pharmaceutical composition for treating coronary heart disease | |
| CN101983712A (en) | Novel medicament for treating coronary heart disease | |
| CN100594916C (en) | Plaster for reducing the blood pressure | |
| CN104645224A (en) | Traditional Chinese medicine preparation for treating costal chondritis | |
| CN106177422A (en) | A kind of Chinese medicine formula of warming YANG to expel cold | |
| CN106038964A (en) | Traditional Chinese medicine composition for treating acute lumbar sprain | |
| CN106618032A (en) | Health care medicine pillow | |
| CN106237069A (en) | A kind of Chinese medicine formula treating coronary heart disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161109 |
|
| RJ01 | Rejection of invention patent application after publication |